Ja. Miklos et al., Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V-H genes show frequent use of V1-69 with distinctive CDR3 features, BLOOD, 95(12), 2000, pp. 3878-3884
Salivary gland mucosa associated lymphoid tissue (MALT) type lymphomas are
B-cell neoplasms that develop out of a reactive infiltrate, often associate
d with Sjogren's syndrome. Previous reports from our laboratory involving 1
0 patients suggested these lymphomas expressed a restricted immunoglobulin
(Ig) VH gene repertoire with over use of V1-69 gene segments. To better det
ermine the frequency of V1-69 use and whether there may also be selection f
or CDR3 structures, we sequenced the VH genes from 15 additional cases. Ove
r half of the potentially functional VH genes (8 of 14) used a V(H)1 family
V1-69 gene segment, whereas the other cases used different gene segments f
rom the VH1 (V1-46), V(H)3 (V3-7, V3-11, V3-30.3, V3-30.5), and V(H)4 (V4-3
9) families, The 8 V1-69 V-H genes used 5 different D segments in various r
eading frames, but all used a J4 joining segment. The V1-69 CDR3s showed re
markable similarities in lengths (12-14 amino acids) and stretches of 2 to
3 amino acids between the V-D and D-J junctions. They did not resemble CDR3
s typical of V1-69 chronic lymphocytic leukemias. This study extends our ea
rlier work in establishing that salivary gland MALT lymphomas represent a h
ighly selected B-cell population. Frequent use of V1-69 appears to differ f
rom MALT lymphomas that develop at other sites, The high degree of CDR3 sim
ilarity among the V1-69 cases suggests that different salivary gland lympho
mas may bind similar, if not identical epitopes, Although the antigen speci
ficities are presently unknown, similar characteristic CDR3 sequences are o
ften seen with V1-69 encoded antibodies that have anti-IgG or rheumatoid fa
ctor activity. (C) 2000 by The American Society of Hematology.